...
首页> 外文期刊>BMC Cancer >Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
【24h】

Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

机译:体重指数增加了乳腺癌的淋巴结转移风险:具有来自20个队列研究的52904名受试者的剂量 - 反应荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BackgroundSince body mass index (BMI) is a convincing risk factor for breast cancer, it is speculated to be associated with lymph node metastasis. However, epidemiological studies are inconclusive. Therefore, this study was conducted to investigate the effect of BMI on the lymph node metastasis risk of breast cancer.MethodsCohort studies that evaluating BMI and lymph node metastasis in breast cancer were selected through various databases including PubMed, PubMed Central (PMC), Web of science, the China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals (VIP) and Wanfang Data Knowledge Service Platform (WanFang) until November 30, 2019. The two-stage, random effect meta-analysis was performed to assess the dose-response relationship between BMI and lymph node metastasis risk. Between-study heterogeneity was assessed using I sup 2 /sup. Subgroup analysis was done to find possible sources of heterogeneity.ResultsWe included a total of 20 studies enrolling 52,904 participants. The summary relative risk ( RR ) (1.10, 95% CI : 1.06–1.15) suggested a significant effect of BMI on the lymph node metastasis risk of breast cancer. The dose-response meta-analysis ( RR?= 1.01, 95% CI : 1.00–1.01) indicated a positive linear association between BMI and lymph node metastasis risk. For every 1?kg/msup2/sup increment of BMI, the risk of lymph node metastasis increased by 0.89%. In subgroup analyses, positive linear dose-response relationships between BMI and lymph node metastasis risk were observed among Asian, European, American, premenopausal, postmenopausal, study period less than 5?years, and more than 5?years groups. For every 1?kg/msup2/sup increment of BMI, the risk of lymph node metastasis increased by 0.99, 0.85, 0.61, 1.44, 1.45, 2.22, and 0.61%, respectively.ConclusionBMI significantly increases the lymph node metastasis risk of breast cancer as linear dose-response reaction. Further studies are needed to identify this association.
机译:背景物体体重指数(BMI)是乳腺癌的令人信服的危险因素,推测淋巴结转移有关。然而,流行病学研究不确定。进行了该研究以研究BMI对乳腺癌淋巴结转移风险的影响。通过各种数据库选择评估BMI和淋巴结转移的研究,包括PubMed,Central(PMC),Web科学,中国国家知识基础设施(CNKI),中国科学期刊(VIP)和万方数据知识服务平台(万功)直到2019年11月30日。进行两阶段,随机效应META分析评估剂量 - 反应BMI与淋巴结转移风险的关系。使用I 2-st 2 / sup>评估研究之间的研究之间的异质性。完成了亚组分析,以找到异质性的可能源。培训期包括共有52,904名参与者的共有20项研究。概述相对风险(RR)(1.10,95%CI:1.06-1.15)表明BMI对乳腺癌淋巴结转移风险的显着影响。剂量反应Meta分析(RRα= 1.01,95%CI:1.00-1.01)表明BMI和淋巴结转移之间的阳性线性关联。每1?kg / m 2 增量BMI,淋巴结转移的风险增加了0.89%。在亚组分析中,在亚洲,欧洲,美国,绝经,绝经后的亚洲,欧洲,美国,绝经,少于5?年,超过5年的群体中观察到BMI和淋巴结转移风险的阳性线性剂量 - 反应关系。每1?kg / m 2 BMI的增量,淋巴结转移的风险分别增加0.99,0.85,0.61,1.44,1.45,2.22和0.61%。结论BMI显着增加了淋巴节点转移乳腺癌的风险作为线性剂量反应。需要进一步研究来识别这种关联。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号